作者: Yan Zhang , Shuxia Song , Chunyan Liu , Yue Wang , Xian Xian
DOI: 10.1016/J.CELLIMM.2007.07.003
关键词: HBcAg 、 Cytotoxic T cell 、 Fusion protein 、 Virology 、 CTL* 、 Antigen 、 Biology 、 Immunogen 、 CD8 、 Molecular biology 、 Epitope 、 Immunology
摘要: The major aim of the project was to develop virus-like particles (VLPs) displaying single or multi-epitope hepatocellular carcinomas (HCC) in Escherichia coli and evaluate effect on inducing Ag-specific CD8(+) T cell response antitumor efficacy as candidate vaccines. To this end, hepatitis B virus core (HBc) were used a carrier HCC epitopes. Four epitopes MAGE-1(278-286aa), MAGE-3(271-279aa), AFP1 (158-166aa) AFP2 (542-550aa) fused 3' terminus truncated HBV gene, respectively, conjunctively. Not all recombinant plasmids led expression chimeric proteins strain E. BL21 (DE3), but which are expressed inclusion bodies resulted formation complete "mature" VLPs. coli-derived HBc(1-144) protein self-assembled into VLPs that both morphologically physically similar wild-type ones they still remained activity after purification refolding from 6M urea solution. We also showed could be internalized presented by DCs vitro. Additionally, pulsed with HBc-VLPs induce stronger CTL greater IFN-gamma secretion responding cells compared peptid-pulsed DCs. In B16-pIR-HH tumor therapy model, growth established tumors significantly inhibited immunization using VLP-pulsed DCs, resulting higher survival rate immunized animals. Thus, results current study have demonstrated principal possibility VLP basis HBcAg for creation new type HCC-specific immunogen.